Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Nofech-Mozes

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Genes, Chromosomes & Cancer|October 30, 2020
Case of epithelioid hemangioendothelioma occurring in the postradiation setting for breast cancerElan Hahn, Brendan C Dickson, Abha A Gupta, et al.
Clinical Breast Cancer|September 8, 2018
Including the Ductal Carcinoma-In-Situ (DCIS) Score in the Development of a Multivariable Prediction Model for Recurrence After Excision of DCISLawrence Paszat, Rinku Sutradhar, Limei Zhou, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|May 13, 2011
Is ductal carcinoma in situ with "possible invasion" more predictive of invasive carcinoma than pure ductal carcinoma in situ?Tal Arazi-Kleinman, Petrina A Causer, Sharon Nofech-Mozes, et al.
Journal of Clinical Medicine|July 19, 2016
EMT in Breast Carcinoma-A ReviewJoema Felipe Lima, Sharon Nofech-Mozes, Jane Bayani, et al.
Plos One|June 21, 2017
Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancerJeffrey C Liu, Miriam Zacksenhouse, Andrea Eisen, et al.
Archives of Pathology & Laboratory Medicine|October 7, 2025
Clinicopathologic Features and Genomic Profile of Human Epidermal Growth Factor Receptor 2-Low and Human Epidermal Growth Factor Receptor 2-Ultralow Invasive Breast CarcinomasHarpreet Rai, Elzbieta Slodkowska, Sharon Nofech-Mozes, et al.
Case Reports in Obstetrics and Gynecology|August 29, 2012
Retroperitoneal extraovarian fibrothecoma mimicking a malignant epithelial ovarian carcinomaPatrick Roberts, Sharon Nofech-Mozes, Natalie Coburn, et al.
American Journal of Clinical Pathology|September 19, 2009
CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinomaReda S Saad, Nadia Ismiil, Valérie Dubé, et al.
Annals of Diagnostic Pathology|January 1, 2008
Breast metastasis by medullary thyroid carcinoma detected by FDG positron emission tomographySharon Nofech-Mozes, Robert Mackenzie, Harriette J Kahn, et al.
Journal of Biophotonics|July 26, 2020
Peri-tumoural stroma collagen organization of invasive ductal carcinoma assessed by polarized light microscopy differs between OncotypeDX risk groupBlake Jones, Georgia Thomas, Jillian Sprenger, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Genes, Chromosomes & Cancer|October 30, 2020
Case of epithelioid hemangioendothelioma occurring in the postradiation setting for breast cancerElan Hahn, Brendan C Dickson, Abha A Gupta, et al.
Clinical Breast Cancer|September 8, 2018
Including the Ductal Carcinoma-In-Situ (DCIS) Score in the Development of a Multivariable Prediction Model for Recurrence After Excision of DCISLawrence Paszat, Rinku Sutradhar, Limei Zhou, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|May 13, 2011
Is ductal carcinoma in situ with "possible invasion" more predictive of invasive carcinoma than pure ductal carcinoma in situ?Tal Arazi-Kleinman, Petrina A Causer, Sharon Nofech-Mozes, et al.
Journal of Clinical Medicine|July 19, 2016
EMT in Breast Carcinoma-A ReviewJoema Felipe Lima, Sharon Nofech-Mozes, Jane Bayani, et al.
Plos One|June 21, 2017
Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancerJeffrey C Liu, Miriam Zacksenhouse, Andrea Eisen, et al.
Archives of Pathology & Laboratory Medicine|October 7, 2025
Clinicopathologic Features and Genomic Profile of Human Epidermal Growth Factor Receptor 2-Low and Human Epidermal Growth Factor Receptor 2-Ultralow Invasive Breast CarcinomasHarpreet Rai, Elzbieta Slodkowska, Sharon Nofech-Mozes, et al.
Case Reports in Obstetrics and Gynecology|August 29, 2012
Retroperitoneal extraovarian fibrothecoma mimicking a malignant epithelial ovarian carcinomaPatrick Roberts, Sharon Nofech-Mozes, Natalie Coburn, et al.
American Journal of Clinical Pathology|September 19, 2009
CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinomaReda S Saad, Nadia Ismiil, Valérie Dubé, et al.
Annals of Diagnostic Pathology|January 1, 2008
Breast metastasis by medullary thyroid carcinoma detected by FDG positron emission tomographySharon Nofech-Mozes, Robert Mackenzie, Harriette J Kahn, et al.
Journal of Biophotonics|July 26, 2020
Peri-tumoural stroma collagen organization of invasive ductal carcinoma assessed by polarized light microscopy differs between OncotypeDX risk groupBlake Jones, Georgia Thomas, Jillian Sprenger, et al.
Pageof 13